Stryker
Trade Stryker 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About SYK
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments.
SYK Key Statistics
Stock Snapshot
As of today, Stryker(SYK) shares are valued at $355.16. The company's market cap stands at 135.82B, with a P/E ratio of 46.46 and a dividend yield of 95.0%.
On 2025-11-07, Stryker(SYK) stock moved within a range of $352.50 to $357.50. With shares now at $355.16, the stock is trading +0.8% above its intraday low and -0.7% below the session's peak.
Trading volume for Stryker(SYK) stock has reached 435.29K, versus its average volume of 1.81M.
The stock's 52-week range extends from a low of $329.16 to a high of $406.19.
The stock's 52-week range extends from a low of $329.16 to a high of $406.19.
SYK News
Below is Validea's guru fundamental report for STRYKER CORP (SYK). Of the 22 guru strategies we follow, SYK rates highest using our P/B Growth Investor model ba...
Stryker (SYK) shares attracted attention after the company reported strong third quarter results and raised its full-year 2025 outlook. The positive update was...
Stryker Corporation recently reported its third quarter 2025 results, posting US$6.06 billion in sales and US$859 million in net income, and raised its full-yea...
Analyst ratings
73%
of 33 ratingsMore SYK News
Truist lowered the firm’s price target on Stryker (SYK) to $392 from $407 and keeps a Hold rating on the shares. The company delivered a small revenue beat with...
Stryker Corp ((SYK)) has held its Q3 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of TipRanks Pre...
If you have ever wondered whether Stryker is a hidden value play or just priced for perfection, you are not alone. Let's cut through the noise together. While...
Richard Newitter, an analyst from Truist Financial, maintained the Hold rating on Stryker. The associated price target was lowered to $392.00. Elevate Your Inve...